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Abstract
CELL-MEDIATED CYTOTOXICITY OF
JENSEN TUMOR IN

SPRAGL.JE~DAWI~EY

RA.TS

by Theodore D. Masek

An in

v~tro

system for the study of the cell-mediated

immune response to Jensen Sarcoma (,JS) is described.

'I1he

tumor grew unrestricted and lead to the demise of 80% of
successfully challenged Sprague-Dawley rats (persistors)
while 20% of challenged rats

(regressors) destroyed the

tumor by an unknovm mechanism(s)..

Lymphocytes from both

persistors and regressors were shown to be cytotoxic for

tumor cells in vitro,.

Pretreatment of tumor tar9et cells

with "immune" serum from persistors or regressors had no
ef feet on the in· vitro cytotoxici ty of .lymphocytes from
tumor-challenged rats.

Pretreatment of lymphocytes with

irmnune serum, however, was shown to reduce the ·in· vitro
cytotoxicity of uirmnune" lymphocytes although the effect
was variable and did not correlate well with the in vivo
tumor status.

Lymphocyte stimulation wi.t.h Phytohemmag-glu-

tinin (PHA, a T cell mitogen) was decreased in persister
rats; while Poke Weed mitogen (PWM; a B cell mitogen)
stimulation was increased in persister rats.

Treatment of

"immune" lymph.ocytes with a) supernata.nts from tumor cell

cultures, b) irradiated tumor cells or c) sonicated tumor
cells did not result in increased DNA. synthesis.

The

advantages of the Jensen sarcoma system as a model to
study the mechanisms of cell-mediated immunity are discussed.,
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GENERAL INTRODUC'rION
Immunology began as investigators started to study
the mechanisms involved in the ability.of a host to resist
noxious agents or invasive organismso

The reactions

involved were the result of previous exposure to the same
agent or organism and dealt mainly with antibody-mediated
protection..

Cell-mediated immunity .is the recently studied

branch of immunology that investigates inunune reactions
mediated by cells..

Cell-mediated immune (CMI) reactions

·involve t:r;ansplant.ation immunity, tumor immunity, immunity
to microorganisms and certain fungi and possibly certain
autoimmune diseases,,
Among the first workers to report the foreign tissue
rejection phenomenon were Bashford, Murray and Haaland (4)
in 1908 and Russell

(47) in 1912.

These workers reported

that a mouse tumor transplanted to a rat would survive for
8 days before dying.

If the tumor were transplanted back

to the mouse before eight days, it would continue to

live~

If this tumor were again transplanted back to the same
rat, it would be rejected at an accelerated rate.
(36-38)

Murphy

in 1912-1914, found that Rous sarcoma, would grow

in .immunoincornpetent duck or pigeon embryos but not in
immunocornpetent adult animals and that the tumor growth
could be reversed if adult lymphoid cells were inoculated
with the tumor ..
1

2

Most investigators at that time a.greed that antibodies
were responsible for all forms of immun.i ty.

It was known

that immunity to microorganisms could be passively transferred using irmnune

serum~

Since irn.muni ty to grafted tissue

could not be transferred using serum this phenomenon was
not considered to involve the immune system.

However,

Porter (40) in 1930, Mitchison (3~) in 1954, and Billingham
(5), also in 1954, all succeeded in transferring passive
immunity to certain tumors with immune lymphoid cells but
not with immune serums
In the late 1940's Medawar (30-33) demonstrated that
human skin grafts would be rejected at an accelerated rate if
the recipient had previously received a graft from the same
donor.

The mechanism(s) of these reactions

rem~ined

unclear until the classical work of Weaver, Algire and
Prehn (49) in 1955.

These investigators demonstrated that

lymphocytes mediated tissue rejection.

Their experiment

used chambers containing homologous or allogeneic tissue
enclosed by millipore membranes and placed within the
peritoneal cavity of mice.
~ere

Membranes of two pore sizes

used; one was small enough to exclude cells but not

antibodies and the other allowed cells to

pass~

After

seven days within the animal the tissue within the small
pore chamber was intact while the tissue within the large
pore chamber was destroyed by infiltratinq: lymphoid cells.
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As can be seen in the examples above, cell-mediated
immunity has developed hand in hand with tumor immunology.
The similarities are not only historical.

Evidence now

strongly suggests that tumor reje·:::tion is mediated by the
same reactions as allograft rejection (19).

The role of

lymphocytes as mediators of tumor rejection has been
demonstrated beyond a reasonable doubt by tissue culture
experiments (l,6,29,43).

Data have been presented which

indicate that macrophages play a role in allograft rejection
and possibly tumor rejection (10).
This concept t.hat tumor rejection was indeed an
immunological response mediated by the cel.lula.r arm of the
immune system led investigators to hypothesizf=. that cancer
is· a disease sequential to immunological derangement.

Even

at the turn of this century workers were trying to develop ·
methods of tumor im.rn.unization.

Unfortunab:~ly

many of these

studies confused tumor specific antigens (TSA) with normal
transplantation antigens.

It was not until the development

of inbred animal strains that TSA could be proven to exist.
Gross in 1943 (12), Foley in 1953(7), and Prehn and Main

in 1957 (41) all presented evidence that TSA did exist.

In

the experiments of Prehn and Main tumors were induced by
methylcholanthrene (MCA) which were then transplanted to
syngeneic mice and allowed to form palpable nodules.

If

the tumor were surgically removed, the animal would be more

4

resistant to a second tumor transplant when compared with
the control.

Normal tissue did not sensitize animals against

tumor growth even when it was derived from the same mouse in
which the tumor originated.

Mice which were resistant to

tumor challenge did not reject a skin graft from
in which the tumor was derived.
induced tumors carried TSA.

th~

animal

It was concluded that MCA

Since this classical experiment

TSA have been demonstrated in other tumor models.
In the last 25 years there has been a rapid increase
in information concerning the mechanisms involved in
cellular immunology; however, the exact involvement of such
aspects as soluble mediators, antibodies and other humeral
factors remains unclearo

Most investigators accept that

close contact between immune cells and their targets is a
prerequisite before detectable cytopathic changes occur
(8,9,35,42,50).

The mechanism of cytotoxicity after

attachment is vague.
Gorer (9) in 1956 and Karush and Eisen (27) in 1962
proposed that the cytotoxic effect of immune cells is due to.
small amounts of antibodies by which they adhere to as well
as destroy their targets.

This

~ypothesis

explains the

specificity of lymphocyte-mediated immune reactions.

The

theory does not explain, however, how these cytotoxic
reactions may be carried out in the absence of complement
which is required for antibody cytolysis nor does it explain

5
•..

the cytotoxic effect seen when phytohernagglutinin {PHA)
treated nonimmune, allogeneicr or syngeneic lymphocytes are
plated with target cells.
The allogeneic inhibition hypothesis of the Hellstroms
(13-18), was based on the observations of Snell

(48), made

in 1961, that a homozygous mouse tumor would not grow as well
in Fi mice as it would in the parental strain.

It was

postulated that destruction of a target cell was caused by
contact between the lymphocyte and target cell where
surface structure differed in the two cell typeso

Lympho-

cytes are given a secondary role in cytotoxicity.

Only

structural differences between two cells is necessary for
cytotoxicity i.e. two fibroblasts, each from a separate
allogeneic animal, should have the capability of destroying
each other.

This theory has several distinct

drawbacks~

The hypothesis does not satisfactorily explain how syngeneic
lymphocytes can kill tumor cells which possess only TSA.
Holm and Perlmann (23-26) demonstrated that mixtures of
allogeneic, syngeneic and xenogeneic fibroblasts did not
result in cell damage and that heat-killed lymphocytes were
shown to exert no cytotoxic effect on target

cells~

This

theory cannot explain the observation that parental skin
grafts on Fi hybrids were not rejected.
According to a third theory, cell destruction by
immune lymphocytes and macrophages is caused by the release

6

of a soluble toxic factor {s) from t.he immune lymphocyte
upon contact with the target cell (44-46).

Granger and Kolb

(11) in 1968 and Kramer and Granger (28) in 1972 have
presented experimental evidence in favor of this hypothesis.
The data suggest that toxicity from a soluble factor(s)
nonspecific after release.

is

Attempts at finding soluble

factors in the supernatant of target cell cultures killed
by sensitized lymphocytes have not been successful in many
systems.

The scientists who propose this theory explain

that these soluble factors are probably deposited at high
concentrations at the appropriate site by specific immune
contact between antigen and lymphocytee

These factors are

als6 thought to remain bound to cell membranes not allowing
them to be assayed"

'J:lhis theory explains immune specificity,

surveillance of tumors and cytolysis of target cells without
serious drawbacks.

These theories, however, may not be

mutually exclusive and ma.y overlap in the in vivo situation.
In some current research, scientists are investigating
so called "blocking factor".

1'hese factor (s)

found in the

serum of tumor bearing animals have the capacity to block
lymphocyte-mediated cytolysis by
cell (20-22) .

co~ting

the target

Baldwin has demonstrated in a rat hepatorna

model that factors in serum will block cytolysis by coating
the lymphocytes.,

He has named this "inhibition factor"

Whether or not this blocking is immunologically specific

(2,3).

7

remains to be clarified.
in this regard.

Conflicting data has been presented

There is, however, the hypothesis that the

cellular arm of the immune system i.s·in some way modified or
controlled by humeral factors in the serume
An understanding of the mechanism(s) involved in
allograft and tumor rejection is fundamenta.l to the
elucidation of the processes involved in tumor escape from
the host surveillance system.

One problem in the study of

cell-mediated reactions is in finding a model that allows
easy in vitro study of these reactions.

The confusion in

the first part of this century between TSA and normal
transplantation antigens has led many investigators to use
only syngeneic tumor systems (tumor systems that have
arisen in inbred lines and are maintained in inbred lines)
in immunological studies.

It is the authors opinion that

all immunization experiments dealing with protection against
tumors should use these models.

However, in order to stu.dy

the exact lymphocyte-target.cell mechanisms involved in tumor
cell lysis, other tumor models that react more strongly to
tumor or allografts should be considered.

Since allograft

and tumor rejection are mediated by the same reactions,
allogeneic tumor systems (tumor systems in which the tumors
are developed in one strain but are maintained in a
different strain) may be of use in studies of mechanisms.

8
It is the goal of this thesis to ir1troduce the Jensen
tumor model as a system to investigate the mechanisms(s) of
tumor and allograft rejection.

INTRODUCTION
Cell-mediated im..111unity is thou9ht to play a major
role in tumor rejection

ig

vivo (14)

o

Lymphocytes from

tumor bearing animals have been shown to be cytotoxic for
that tumor in vitro, demonstrated by ei tJ1er colony
inhibition, microcytotoxicity tests or radioisotope
release techniques (9,10,13,22).

The role of humeral

factors in tumor immunity is less clear, although it is
thought that cell-mediated immunity may be modified by
soluble factors found in the serum.
An understanding of the mechanism(s) involved in
tumor immunity is fundamental to the elucidation of the
processes involved in tumor escape from the host surveillance
system.

An association between blastogenesis and the rapid

in vitro destruction of L cells by FHA-stimulated lymphocytes
has been reported (5,6).

Stulting, Todd and Amos (21) have

recently demonstrated that the integrity of the target cell
membrane is necessary.for lymphocyte attachmente

Blasto-

genesis results only after attachment to specific antigens
or stimulation by non-specific mitogens such as PHA or PWM.
Jensen Sarcoma is rapidly growing undifferentiated
pleomorphus-cell tumor which originated in an outbred gray
rat that had been inoculated with an acid-fast bacillus in

O.Ce Jensen's laboratory in 1907e

9

Although termed a

10

sarcoma, Jensen tumor cannot be classified as either a
carcinoma or sarcoma..

In tumor challengF.!d Wis tar or

Sprague-Dawley rats tumor growth is established in 90% but
not demonstrated in the remainder; ·of the 90% which show
tumor growth 80% e'"<rentually succumb to the tumor and 20%
regress spontaneously.

The Jensen system has been used as

·a model to study tlLTUOr cell sensitivity to radiation (19),
metabolic changes of the tumor cell after exposure to
x-rays (15), and the effects of cortisone and insulin on
tumor weight (16) ..

The Jensen tumor has also been used to

study carbon dioxide metabolism (18}.

The host immune

responses toward Jensen sarcoma have not been investigated5
· The purpose of this work is to measure the capability
of lymphocytes from animals in which the tumor spontaneously
regressed (the regressors) and animals in which the growth
of the tumor resulted in the animal;s death (the persistors)
to mediate in vitro cytotoxicity to tumor cells and to study
the correlation of blastogenesis and tumor growthe
following questions are asked:

The

1) When and to what degree

can lymphocyte-mediated cytotoxicity be demonstrated in
regressors and persistors?

2) Will.sera from rats in which

the tumor has regressed or in which the tumor is actively
growing affect lymphocyte-mediated cytotoxicity?

3) Is

there an association between lymphocyte blastogenesis and
tumor destruction?

Ml'.1.. TERIA.L AND METHODS

Animals and In Vivo Tumor..

M.ale Sprague-Dawley rats

(350-400 gms., Holtzman Co., Madison Wisconsin) used in this
study were maintained under standard laboratory conditions.
Animals which had received an I.P. inject.ion of 5 x 10 6
Jensen tumor cells 7 days previously were sacrificed and
the tumor mass removed aseptically

,Jensen cells produced

o

tumor more consistently and rapidly in the muscles of
experimental animals if they were conditioned by a passage
·in vivo (I. P. ) .

rhe tumor was minced and teased to release

1

individual cells, suspended in Hanks Balanced Salt Solution
(HBSS) and strained through sterile gauze to remove large
fragmentso

Experi~ental

animals were inoculated I.Me with

lGO x 107 Jensen tumor cells in the righi thigh~
Jensen Tumor Mainten·ance.

Jensen tumor cultures

originally obtained from R .. E. Beltz

(Lorna Linda University,

Lorna Linda, Cae) were maintained in our laboratory under·
standard in vitro conditions.

The original culture was

maintained in plastic tissue culture flasks
Plastics, Los Angeles,

Ca.)~

(Falcon

When sufficient numbers of

cells were available, 1.0 ml samples containing 1.0 x 10 6
cells in 7% dimethyl sulfoxide were frozen and stored at

-60 C.

All Jensen tumor cells used in experiments were

utilized within 20 in vitro passages.
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Cell Culture and Medium.

C~ll

culture medium

utilized in routine cell culture and experiments consisted
of RPMI 1640 (Grand Island Biological Co., Grand Island,
New York)

supplemented with 10 percent fetal calf serum (FCS) ,

•

100 u/ml pencillin and 100 J\.g/ml streptomycin.
medium (CM) which was used in

microass~ys

Conditioned

consisted of 45%

fresh media, 45% media from 24-48 hour Jensen tumor cell
cultures and 10%

FCS~

Cell cultures were maintained in

sealed 250 ml plastic flasks incubated at 37 C.

The

cultures were passed twice weekly or when the monolayers
became 90 -

95% confluent.

Lymphocyte Separation.

A Ficoll-Hypague density

gradient centrifugation, separated lymphocytes from whole
heparinized blood (50

u /ml) which had been obtained by

cardiac puncture (17,3).

A 2.0 ml aliquot of whole blood

was diluted 1:3 in 0.15 M saline and layered onto 3.0 ml of
Ficoll-Hypaque.

After centrifugation at 400 x g for 40 min.

i.n a Sorvall GLC-2 centrifuge, the purified lymphocytes were

collected by aspiration from the aqueous Ficoll-Hypaque
interface.

The lymphocytes were washed 2X in HBSS, a

viable count was performed using a hemacytometer and the
cells finally resuspended at a final concentration of
5 x 10 5 per ml.
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Cell-Mediated _Cytotoxici 1:-.Y_ 'T~st.,

Lymphocyte in vitro

cytotoxicity was assayed by a modification of the method
described by Hellstrom et al.

(12).

Fifty to 100 target

cells in 0.2 ml CM were plated in Falcon Microtest II
plates (Falcon Plastics Coe, Los Angeles, California) and
incubat~d

for 24 hr at 37 C to allow target cell attachmente

Subsequent to this the medium was decanted and replaced
with Oa2 ml of fresh medium containing 0.25 x 105, 0.5 x 105·
and leO x 105 lymphocytes from experimenta~ or control
nonchallenged animals and the cultures incubated further for
two days.,

The cultures we:r.e then w·ashed two times with 0. 2 ml

HBSS, fixed for 30 minutes with absolute methanol, staihed
with Giemsa stain and the remaining cells counted under an
inverted microscope.

The mean number of attached cells in

wells incubated with experimental lymphocytes was compared
with the mean number of attached cells in wells cultured
with control lymphocytes and expressed as percent cytotoxicity
utilizing the following expression:

% cytotoxicity

=

Number of cells in control wells 100 x Number of cells in experimental wells
Number of cells in control wells

Ser1m Blocking Activity.

Sera obtained from blood

collected by cardiac puncture were tested for their ability
to protect target cells from aggressor lymphocytes.

Target

cells were seeded into microtest pretreated plates as before.
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The medium was then replaced with 0.1 ml of a 1:5 dilution
of heat inactivated (50 C/30 min) test serum or normal
control serum.

After 45 minutes incubation at 37 C the

serum was removed, lymphocytes from

r~~gress.ors

or control

animals were added and a cytotoxicity assay was performed
as previously described.
Test for Serum Inhibitory

Act~v~_ty..

'rhe method of

Baldwin, Price and Robins (2) was used to determine the
direct effect of

"immun~"

sera from tumor bearing animals

on the cytotoxic response of immune lymphocytes.

•rest and

control heat inactivated sera were diluted 1:3 in HBSS and
0. 3 ml ·was placed into a 0. 2 ml sample of RPMI medium
containing· LO x 106 or O 5 x 106 lymphocytes from control
c;

or regressor animals.

The mixture was then incubated at

37 C for 60 minutes with occasional shaking, centrifuged at
120 x g for 5 min and the lymphocytes resuspended in 2.0 ml
of RPMI 1640.

The treated lymphocytes were tested for their

ability to kill J"ensen tumor cells in vitro. in the standard
cytotoxicity assay as described abovec
·Lymphocytt:.: Transformatio·n

Te~t_~

Triplicate cultures

containing 1.0 x 106 peripheral blood lymphocytes in 0.5 ml
RPMI 1640 medium v.rere prepared in 12 x 70 mm Falcon plastic
culture tubes {Falcon Plastics, Los Angeles, Ca.)
cyte cultures were then treated with 25

.J'\ g

a

Lympho-

PHA-P (DIFCO,

15
Detroit,

Michig~n)

in 0.1 ml HBSS, 1:20 dilution of Poke

Weed Mitogen (PWM, DIF'CO), or 0 .. 1 ml HBSS only and
incubated for 72 hours at 37 C in a

CO~
.w

incubator (National

Appliance Co., model 3221, Portland, Oregon).
this 2 C of

3H~-thymidine

Subsequent to

(specific acti.vi ty 6. 0 Ci/mmole,

Schwarz-Mann, Orangeburg, N.Y.) was added to each culture
and the cells incubated an additional 12 hours.

Then each·

culture was washed 3 times with cold PBS, the cells disrupted
with lN NaOH and the nucleic acid precipitated with 5 percent
TCAe

The precipitate was collected on a 0.45

Millipore

filter~

m pore size

The incorporation of 3H-thymidine was then

determined in a Nuclear-Chicago {Chicago, Illinois) liquid
scintillation counter.

The stirnuiation index was calculated

as follows:
Stimulation index

=

CPM in mitbgen st~mulated cultures
CPM in unstimulated control cultures

RESUUrs

Kinetics of Direq_.!:

Lvmp!.!_~cyte.mmediateq __5;_ytotoxicity

of Tumor

Challenged Animals
Target cells were established.in Microtest II plates
as described in the text and treated with lymphocytes
obtained from peripheral blood just before tumor transplant
.Cday 0) and at different days after tumor challenge.
Titrations were performed with different effector to target
cell (E/T) ratios to determine at what ratio the peak
activity could be found.

An E/T ratio of 2000:1 was

demonstrated to be the ratio in which the highest cytotoxic
activity could be found.
cytotoxicity
500:1.

as~ays

Figure 1 represents the data from

using 3 E/T ratios, 2000:1, 1000:1 and

At the E/T ratio of 2000:1 cytotoxicity was first

detected between days 4 and 8 in both the regressors (15.9%)
and persistors (10.1%)

e

Th~

percerit cytotoxicity peaked at

day 21, regressors (80.4%) and persistors (78e9%), and
remained high in those animals tested between days 30 and 40
after tum6r challenge.

Cytotoxicity could be demonstrated

at this E/T ratio in regressors on day 100, all persistors
died within 65 days after tumor challengee
To test the possibility that high E/T ratios might
mask a difference in direct cytotoxicity between regressors
and persistors, cytotoxicity was determined at lower E/T

16

Figure 1

Direct Cytotoxicity of effector cells from regressor and
persistor animals.

Peripheral blood lymphocytes were collected

at various days following tumor challenge and tested in vitro
as described in the text ( e ·- e

, reg:ressor,

A -- £

persister) .
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ratios.

There was variability in the

m~gnitude

cytotoxic response at different E/T ratios.

of the

However, the

same pattern of response was demonstrated ·and only small or·
no differences between regressors and persistors could be
detected.

At the

E/~

ratio of 1000:1 cytotoxicity was not

demonstrated until day 14 in comparison with day 6 at
ratio

2000:1~

The peak response was on day 20 the same as

the E/T ratio of 2000:1 but to a lesser degree:
(42.3%)

vs.,

(80o4%)

and persistors (48.5%) vs.

regressors
(78.9%) ..

A response was also detected between days 30 and 40 in
both regressors and

p~rsistors.

lowered to 500 :·l a defi.ni te
20, regressors

When the E/T ratio was

responst~

(13.6%), persistors

between days 30 and 40.

wc-:s demonstrated on day

(18.8%) and remained

These data show that strong cytotoxic

response is demonstrated in vitro regardless of tumor status
in vivo and that the magnitude of the response is related to
the E/T ratio and to the time after tumor challenge ..
Effect of Serum Coated Target Cells on Direct Lymphocyte
Cytotoxicity
Target cells were again plated into Microtest I I
plates as described above.

Sera obtained at different days

after tumor challeng-e from normal controlsr persistors or
regressors was added and the plates incubated for 45 minutes.
The serum was then decanted and effector cells added.
results of these experiments

(Table· l) demonstrate that

The

20

TABLE 1
Effect of Serum Coated Target Cells on Direct
Lymphocyte Cytotoxicity
Day After
Tumor
Transplant

% Blockinga

Persis tor

Regressor

6

0

0

16

0

2.1

20

0

8.0

49

0

0

Target cells were treated with sera from control,
tumor bearing persistors or regressors as described
in text. Cytotoxicity was determined at E/T ratio
2000:1
% cytotoxicity 0 day a% Blocking = 100 x % cytotoxicity test day
% cytotoxic:Ct.y-0 day -

21
serum from persistors had no effect on direct lymphocytemediated cytotoxicity and that serum from regressors had
little or no effect.
Effect of Serum Coat.:;;d Lymphocytes

or~. C~tC?toxici ty

Baldwin, Price and R6bins have demonstrated that
sera from tumor bearing animals, but not regressors, can
block lymphocyte-mediated cytotoxicity by coating the
lymphocyte (2).

To investigate the possibility that a

similar mechanism may play a role in the J'ensen tumor model,
effector lymphocytes were treated with serum from normal
control, regressors

or

persistors obtained at different

days after tumor chailenge.

These lymphocytes were then

added to Jensen tumor target cells in Microtest II plates
and a standard lymphocyte-mediated cytotoxicity test

The experiment was

performed as described in the text.

repeated a total of three times utilizing
different animals.

se~um

from

The data which represents a typical

experiment can be seen in Table 2.

At the E/T ratio of

2000:1 only the persistors' serum was tested since
previous work by other investigators has

sl~own

that only

the persistors produce consistent inhib£tion throughout
the disease (1,9).

Definite inhibition activity was

demonstrated only on day 16

( 39 .. 0%)

~

1'he E/'l' ratio was

lowered to see if this effect was being masked by the
amount of sensitized lymphocytes.

At the E/T ratio of

lar~e
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TABLE 2
Effect of Serum Coated Lymphocytes on Cytotoxicity
Day After
Tumor
Transplant

% Inhibitiona

Persistor

Regressor

6

2~1

N.T

E/T Ratio

16

39 .. 0

N.T

2000:1

20

.. 63

N.'r

49

0

N.T

6

E/T Ratio

16

1000:1

24

47

157.4
0

65.8
0

0

92.6

0
0

Lymphocytes were pretreated with sera from control, tumor
bearing persistors or regressors as described in the text.
Cytotoxicity was determined at E/T ratios of 2000:1 and
1000:1
% cytotoxicity by lymphocytes treated

a%

Inhibition

=

with normal serum % cytotoxicity by iymphocytes treated
with test serum
100 .x _%_c_y_t_o_t-oxici ty by ly-._m_p_h_.y_c_y_t_e_s_t_r_e_a_t_e.d
with normal serum

23
1000:1 inhibition factor was demonstrated on day 6 and
day 20 and the percent inhibition increased to 157.4% and
65.8%

respectively~

However, even the regressors' serum

showed 92.6% inhibition on day 16.

It is evident from

these data that inhibition factor can be demonstrated but
that it is sporadic and does not correlate with in vivo
tumor status.
Lymphocyte Response to Mitogen Stimulation from Regressor,
Persister and Control Animals
Triplicate cultures of lymphocytes, from normal
control, regressors or persistors were set up with and
without mitogen.

After 48 hours incubation, the cultures

were pulse labeled for 12 hours with 3H-thymidine.

The

cultures were then harvested and the incorporation of
3H-thymidine determined in a liquid scintillation counter.
The results of these experiments using PHA and PWM are
represented in Figure 2.

When PWM, a B-cell stimulator,

was used, the normal controls and regressors gave similar
stimulation indices, 9.2± 2.0 and 12.9± 4.2 respectively.
Persistors gave an increased response, 21.0± 9.7.

Fifty

percent of the persistors had stimulation indices above
the highest index found in the control whereas the other
half fell within the normal range explaining the relatively
high standard error.

When PHA, a T-cell stimulator was

used as the mitogen the regressors had an increased

Figure 2
Lymphocyte response to rnitogen stimulation from regressor,
persister and control animals.

A comparison of lymphocytes

to incorporate 3H-thymidine after exposure to PWM (top) or
PHA (bottom) as described in the text.

The mean value of 6-8

animals for each group is given with the standard error.
astimulation index

=

CPM of cultures with mitogen
CPM of cultures without mitogen
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stimulation index (24~6± 8.8) compared with the control
(13.6± 2.6).
The~e

The persistors' index was depressed (7.0± 2.4).

data suggest that lymphocytes from·regressors and

persistors differ in their ability to.respond to PWM and
PHA and that these differences may be associated with tumor
success in vivo.
Attempts at Lymphocyte Stimulation by Various Tumor Cell
Components
We next designed an experiment to stimulate the cells
with whole tumor cells, supernatant fluid or sonicated
tumor cells to investigate whether or not stimulation
patterns we demonstrated with mitogen were also demonstrable
with a specific antigen(s).
obtained in.this experiment.

Table 3 presents the data
All attempts at stimulation of

lymphocytes with tumor cell components failed.

TABLE 3
Attempts at Lymphocyte Stimulation by Various Tumor Cell Components

Target Cell/
Lymphocyte
Ratio·

Stimulation Index 1

Ir~adiatea2
Whole Cells
Immune
Control

2:1

1. 5

1:5

Ll

1:10

1. 2

1:100

1stimulation index =

Supernatant 4
Immune
Control

.42

.1

.43

.64

.39

.33

.21

.42

.46

.67

.. 48

.21

.51

.1

1. 4

.80

Sonicated Tumor Cells3
Immune
Control

1.. 2

. cpm in lymphocyte cul ture·s with lymphocytes arid -tumor-cell
component._ _ _ _ _ _ _ _ _ _ _ _ __
cpm in lymphocy'te cultures without tumor components

2 control value

=

2026

3 control value

=

1832 S.E.

±

484

±

365

4 Effect of supernatants from tumor cell cultures undiluted and diluted 1:10
control 1695 ± 298

DISCUSSION
Three main findings restilted from this study.

First,

the tumor cell line was shown to be immunogenic in that
lymphocytes from ~nimals receiving tumor transplants kill
target cells in vitro.

Second, sera from neither persistors

nor regressors will block the cytotoxic effect of sensitized
lymphocytes.

Sera will block the cytotoiic effect by

coating lymphocytes; however, this effect is sporadic and
does not correlate with in vivo tumor status.

Third,

persistors' lymphocytes do not respond as strongly to PHA
stimulation as do normal control animals.

Regressors had

an increased stimulation index above that of the control
when stimulated by PHA.
The finding that lymphocytes are cytotoxic to tumor
cells regardless of tumor status in vivo is in agreement
with findings from other investigators using other tumor
models (1,7,9).

One hypothesis introduced to explain why

tumors grow persistently

~n

vivo in spite of the fact that

they can be killed in vitro by lymphocytes from the tumor_
bearing animals is that the lymphocytes are inhibited
in vivo by factors in immune seia (2,9-11).

These factors

do not appear to play a major role in tumor success in the
I

Jensen tumor system.

When target cells were coated with

sera from challenged animals, cytotoxicity was not altered.
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sera from challenged animals.
•

,

· ·.. - ·

~.-

This inhibitory effect was,

·;

r: ..

'l _;:

. ·

.

·· i_ .,_. ,

:~.

,

.

.- •

•

however, only in sporadic examples.in both·persistors and
regressors.

These observations on the inhibitory effect of

sera are intriguirtgo

However, it is necessary to separate·

specific immune inhibition, nonspecific inhibition and to
test procedural artifacts.
answer these questions.

Further studies are needed to

It would be extremely helpful to

isolate the factors from the serum and describe their
biochemical nature.

Data is still not yet available six

years after these serum blocking factors were first
described ..
The Jensen tumor arose in an outbred population of
rats (20).

It is interesting to note

tha~

80 percent of the

successfully challenged rats succumb to the tumor and die.
The study of the mechanism(s) involved in the tumor success
may prove useful in the elucidation of how tumors escape
the host immune surveillance system.

Further investigation

may also give insight into the exact cytotoxic mechanism of
allograft rejection.
We would also like to point out! that the depressed
T-cell function of the persistors, measured by PHA stimulation,
may play a role in tumor success.

It may be hypothesized that

the high ratio of lymphocytes to target cells in the microcytotoxicity assay may make the a.ssay more sensitive than

3Q
the in vivo situation~

bk§

''

b~rh~~g~ sirliilar, to "concomitant

immunity" described by Gershon

(4)~

;

If this factor is

linked with a mal~unctioning T-cell population in the
persister, the tumor may simply outrun the host immune
system.
The fact that sensitized lymphocytes failed to
increase their uptake of tritiated thymidine when exposed to
irradiated cells, sonicated tumor cells or supernatant may
be explained in llght of the recent findings of Stulting,
Todd, and Amos (21).

They demonstrated that sensitized

lymphocytes directed against allogenic antigens recognize
and bind to an antigenic complex whose organization is
dependent upon the.integrity of the target cell membrane.
j

.

It is possible that.the lensen tumor antigen is a complex
whose organization is dependent upon the integrity of the
target cell membrane.

Thus, the antigen would not be

released into the supernatant fluid.

Irradiation and

sonication may disrupt this complex making it unrecognizable
to the sensitized lymphocytes.
The Jensen tumor system would seem to of fer several
advantages in studies concerning immunological mechanisms.
The system is easy to maintain both in vivo and in vitro.
It, also, is very tumorigenic.

Transplants are successful

in over 90% of the animals challenged and lead to the demise
of 80% of these animals.

The fact that the tumor is

..
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allogeneic a.nd still :is

only

rejected by 20% of the animals

presents a stimulating question on the mechanism(s) involved
in tumor success.

In this system the cytotoxic lymphocyte

response was higho

Many animals gave 100 percent cytotoxicity

indices at 21 days after tu.mar challenge ..

These findings

resolve the question as to whether or not the visual cytotoxici ty assay (used in this paper) only measured inhibition
of growth and not cell lysis.

Rat lymphocytes can be easily

obtained £ram lymphoid organs or peripheral blood by cardiac
puncture.

These cells are relatively stable in vitro

offering another advantage of this tumor model.
The immunological parameters of the Jensen system
have been

describ~d.

It is our opinion that further studies

with this system will offer insight into the mechanism(s)
involved in tumor and allograft rejections ·o

Since the

tumor first arose in an outbred population it may be useful
in trying to bridge the gap between studies of tumors in
inbred strains of animals and studies in man.
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